trending Market Intelligence /marketintelligence/en/news-insights/trending/fxulzcoqkph0mxomnmiu7w2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Oramed Pharmaceuticals closes $18.1M common stock, warrants offering

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates

Blog

COVID-19 Impact & Recovery: Investment Banking


Oramed Pharmaceuticals closes $18.1M common stock, warrants offering

Oramed Pharmaceuticals Inc. said July 6 that it closed its registered direct offering with certain healthcare-focused institutional investors to raise about $18.1 million in gross proceeds.

The Israeli company offered 2,892,000 common shares and warrants to buy up to 2,892,000 common stock at a combined price of $6.25 per share and related warrant. The warrants will be exercisable six months after being issued at $7.25 per share.

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.